Martín Moro Fernando

14PUBLICATIONS
39CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 18, 2026
Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network.

|Jan 28, 2026
Apheresis CD8+CCR7+CD45RA- T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.

Iván García de la Torre, Carlota García-Hoz, Fernando Martin-Moro

|Mar 31, 2025
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.

Leyre Bento, Antonio Gutiérrez, Carmen Martínez

|Mar 27, 2024
Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis.

Fernando Martin-Moro, Javier Lopez-Jimenez, Jose A Garcia-Marco

|May 31, 2023
Acute leukemia of ambiguous lineage, not otherwise specified with FLT3-ITD mutation and a possible origin in the common lymphoid progenitor.

Fernando Martin-Moro, Jose A Garcia-Vela

|Apr 21, 2023
Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.

Claudia Núñez-Torrón Stock, Carlos Jiménez Chillón, Fernando Martín Moro

Pageof 3

Frequent Collaborators

4 joint publications

José Antonio García-Vela

3 joint publications

Juan Marquet-Palomanes

2 joint publications

Javier Lopez-Jimenez

1 joint publications

Claudia Núñez-Torrón Stock